Examining the relationship between ovarian reserve, as measured by basal FSH levels, and the risk of poor obstetric outcome in singleton IVF gestations

Human Reproduction

Volumn 26, Issue 12, 2011, Pages 3424-3430

  Calhoun, K C ^a   Fritz, M A ^a   Steiner, A Z ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

assisted reproduction technology; diminished ovarian reserve; FSH; low birthweight; preterm birth

Indexed keywords

CLOMIFENE; FOLLITROPIN;

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; GESTATIONAL AGE; HUMAN; INFANT; LIVE BIRTH; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVARIAN RESERVE; PREGNANCY OUTCOME; PREMATURE LABOR; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

EID: 81055132906     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der311     Document Type: Article

References (39)

1. Addor V, Santos-Eggimann B, Fawer CL, Paccaud F, Calame A. Impact of infertility treatments on the health of newborns. Fertil Steril 1998; 69:210-215.
2. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996;87:163-168.
3. Allen C, Bowdin S, Harrison RF, Sutcliffe AG, Brueton L, Kirby G, Kirkman-Brown J, Barrett C, Reardon W, Maher E. Pregnancy and perinatal outcomes after assisted reproduction: a comparative study. Ir J Med Sci 2008;177:233-241.
4. Axmon A, Hagmar L. Time to pregnancy and pregnancy outcome. Fertil Steril 2005;84:966-974.
5. Basso O, Baird DD. Infertility and preterm delivery, birthweight, and Caesarean section: a study within the Danish National Birth Cohort. Hum Reprod 2003;18:2478-2484.
6. Chung K, Coutifaris C, Chalian R, Lin K, Ratcliffe SJ, Castelbaum AJ, Freedman MF, Barnhart KT. Factors influencing adverse perinatal outcomes in pregnancies achieved through use of in vitro fertilization. Fertil Steril 2006;86:1634-1641. Epub 2006.
7. Freeman SB, Yang Q, Allran K, Taft LF, Sherman SL. Women with a reduced ovarian complement may have an increased risk of a child with Down Syndrome. Am J Hum Genet 2000;66:1680-1683.
8. Helmerhorst FM, Perquin DA, Donker D, Keirse MJ. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. Br Med J 2004;328:261.
9. Henningsen AKA, Pinborg A, Lidegaard O, Vestergaard C, Forman JL, Andersen AN. Perinatal outcome of singleton siblings born after assisted reproductive technology and spontaneous conception: Danish national sibling-cohort study. Fertil Steril 2011;95:959-963.
10. Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 2004;103:551-563.
11. Jain T, Soules MR, Collins JA. Comparison of basal follicle stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril 2004;82:180-185.
12. Joffe M, Li Z. Association of time to pregnancy and the outcome of pregnancy. Fertil Steril 1994;62:71-75.
13. Kallen B, Finnstrom O, Lindam A, Nilsson E, Nygren KG, Olausson PO. Blastocyst versus cleavage stage transfer in in vitro fertilization: differences in neonatal outcome? Fertil Steril 2010;94:1680-1683.
14. Kansal Kalra S, Ratcliffe SJ, Milman L, Gracia CR, Coutifaris C, Barnhart KT. Perinatal morbidity after in vitro fertilization is lower with frozen embryo transfer. Fertil Steril 2011;95:548-553.
15. McGovern PG, Llorens AJ, Skurnick JH, Weiss G, Goldsmith LT. Increased risk ofpreterm birth in singleton pregnancies resulting from in vitro fertilization-embryo transfer or gamete intrafallopian transfer: a meta-analysis. Fertil Steril 2004;82:1514-1520.
16. McGregor JA, Leff M, Orleans M, Baron A. Fetal gender differences in preterm birth: findings in a North American cohort. Am J Perinatol 1992;9:43-48.
17. Meekins JW. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994;101:669-674.
18. Muasher SJ, Oehninger S, Simonetti S, Matta J, Ellis LM, Liu HC, Jones GS, Rosenwaks Z. The value of basal and/or stimulated serum gonadoptropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 1988;50:298-307.
19. Nasseri A, Mukherjee T, Grifo JA, Noyes N, Krey L, Copperman AB. Elevated day 3 serum follicle stimulating hormone and/or estradiol may predict fetal aneuploidy. Fertil Steril 1999;71:715-718.
20. Norwitz ER. Review: Defective Implantation and placentation: laying the blueprint for pregnancy complications. RBM Online 2006;13: 591-599.
21. Perri T, Chen R, Yoeli R, Merlob P, Orvieto R, Shalev Y, Ben-Rafael Z, Bar-Hava I. Are singleton assisted reproductive technology pregnancies at risk of prematurity? J Assist Reprod Genet 2001;18:245-249.
22. Romundstad LB, Romundstad PR, Sunde A, von Düring V, Skjaerven R, Gunnell D, Vatten LJ. Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study. Lancet 2008;372:737-743.
23. Schieve LA, Ferre C, Peterson HB, Macaluso M, Reynolds MA, Wright VC. Perinatal outcome among singleton infants conceived through assisted reproductive technology in the United States. Obstet Gynecol 2004; 103:1144-1153.
24. Sharif K, Elgendy M, Lashen H, Afnan M. Age and basal follicle stimulating hormone as predictors of in vitro fertilization outcome. Br J Obstet Gynaecol 1998;105:107-112.
25. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785-799.
26. Slattery MM, Morrison JJ. Preterm Delivery. Lancet 2002;360:1489-1497.
27. Society for Assisted Reproductive Technology. What is SART? http://www. sart.org.
28. Steiner AZ. Clinical implications of ovarian reserve testing. Obstet Gynecol Surv 2009;64:120-128. Review.
29. Stephansson O, Kieler H, Granath F, Falconer H. Endometriosis, assisted reproduction technology, and risk of adverse pregnancy outcome. Hum Reprod 2009;24:2341-2347.
30. Tanbo T, Dale PO, Lunde O, Moe N, Abyholm T. Obstetric outcome in singleton pregnancies after assisted reproduction. Obstet Gynecol 1995; 86:188-192.
31. Toner JP. Age - egg quality, FSH level - egg quantity. Fertil Steril 2003; 79:491.
32. Toner JP, Philput CB, Jones GS, Muasher SJ. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784-791.
33. Van der Steeg JW, Steures P, Eijkemans MJ, Habbema JD, Hompes PG, Broekmans FJ, Bouckaert PX, Bossuyt PM, Van der Veen F, Mol BW. Predictive value and clinical impact of basal FSH in subfertile, ovulatory women. JCEM 2007;92:2163-2168.
34. Van Montfrans JM, Dorland M, Oosterhuis GJ, Van Vugt JM, Rekers-Mombarg LT, Lambalk CB. Increased concentrations of follicle-stimulating hormone in mothers of children with Down's syndrome. Lancet 1999;353:1853-1854.
35. Walker JJ. Pre-eclampsia. Lancet 2000;356:1260-1265.
36. Wang YA, Sullivan EA, Black D, Dean J, Bryant J, Chapman M. Preterm birth and low birth weight after assisted reproductive technology-related pregnancy in Australia between 1996 and 2000. Fertil Steril 2005;83:1650-1658.
37. Wang T, Zhang J, Lu X, Xi W, Li Z. Maternal early pregnancy body mass index and risk of preterm birth. Arch Gynecol Obstet 2010. [Epub ahead of print].
38. York TP, Strauss JF, Neale MC, Eaves LJ. Racial differences in genetic and environmental risk to preterm birth. PLoS One 2010;5:e12391.
39. Zhu JL, Obel C, Hammer Bech B, Olsen J, Basso O. Infertility, infertility treatment, and fetal growth restriction. Obstet Gynecol 2007; 110:1326-1334.